Investment
Features
FeesSafety
Academy
More
Pluang+
|
Home/Explore/US Market Price/Stocks/REGN
icon
Up to 4x
Us company
Asset icon - trade crypto, stocks, and gold on Pluang

Regeneron Pharmaceuticals Inc (REGN) Stock Price Today

TechnicalsFundamentalsFinancialsNewsCorp ActionAboutCompare
24H
1W
1M
3M
YTD
1Y
5Y

Aura AI Summary

Regeneron Pharmaceuticals (REGN) trades at $852.03, up 3.42% today, with a bullish technical signal from moving averages and strong fundamental profitability. The company reported robust earnings beats in recent quarters, with Q3 2026 EPS expected at 16. Revenue grew to $14.34B in 2025, supported by an 84.86% gross margin and 27.86% net income margin. However, the stock faces headwinds from multiple class-action lawsuits related to a Phase 3 clinical trial disclosure, creating near-term sentiment pressure despite solid financials.
The outlook for REGN is mixed: strong earnings momentum and analyst consensus support a bullish view, but legal risks and trial outcomes pose significant downside. Investors should weigh the company's high profitability and growth against litigation uncertainties. The stock's current price is above the consensus target of $756.82, suggesting limited upside unless positive clinical or financial catalysts emerge.
Read full analysis

Key Stats

  • Market Cap
    $87.72B
  • Volume
    -
  • Sector
    Health
  • 52W High
    $852.03
  • 52W Low
    $555.51
  • Typical Hold Time
    -
  • Enterprise Value
    $82.43B
  • Div Yield
    0.44%
  • Trading Activity
    -
$843.47
52W Low: $555.51
25 Sep 2025
52W High: $852.03
02 Sep 2026

Track Regeneron Pharmaceuticals Inc (REGN) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Regeneron Pharmaceuticals Inc has traded between a low of $555.51 and a high of $852.03, highlighting its annual price range. Buy and sell Regeneron Pharmaceuticals Inc shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.

About Regeneron Pharmaceuticals Inc

Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation. The company has several marketed products, including Eylea, approved for wet age-related macular degeneration and other eye diseases

Most Recent News

Content is generated by Aura AI

Nissan deploys AI robots hauling 4,000 lbs to cut costs and boost factory efficiency

Nissan is rolling out AI-powered autonomous mobile robots (AMRs) at its Smyrna, Tennessee factory to transport heavy loads up to 4,190 pounds. These robots can recharge themselves, communicate to avoid traffic jams, and call for backup if needed, rep...

Market News
4 hours ago
Business Insider
Bullish
news icon
Nissan deploys AI robots hauling 4,000 lbs to cut costs and boost factory efficiency

ON Semiconductor aims to boost physical AI with Synaptics acquisition, enhancing robotics and automation tech.

ON Semiconductor is focusing on physical AI by enhancing its semiconductor capabilities in power, sensing, and control, crucial for robotics and automation. The proposed acquisition of Synaptics will fill gaps in edge computing and tactile sensing, m...

Market News
4 hours ago
Seeking Alpha
Bullish
news icon
ON Semiconductor aims to boost physical AI with Synaptics acquisition, enhancing robotics and automation tech.

Fiinu shares jump 6% as its Plugin Overdraft platform goes live with Conister Bank partnership

Fiinu, a UK fintech company, saw its shares rise over 6% after its Plugin Overdraft platform entered production following a revised agreement with Conister Bank. The updated deal sets a new timeline and commercial framework for launching a proof-of-c...

Market News
4 hours ago
Proactive Investors - Finance
Bullish
news icon
Fiinu shares jump 6% as its Plugin Overdraft platform goes live with Conister Bank partnership
Catch up fast with Aura AI
Get an AI-generated news summary for this asset in seconds.

People also bought

Frequently Asked Questions

US stocks trading hours: Monday - Friday (Except for US public holidays) Time: 21.30 - 04.00 WIB 20.30 - 03.00 WIB (Daylight Savings Time*) *The next Daylight Savings is scheduled to begin on March 13, 2022 and ends on November 6, 2022. You can place limit orders outside of the trading hours, but it can only be executed during trading hours. For illustration, a stock is currently trading at $10 per share, but you only want to pay $7 per share at most. Let’s say you set your limit price to $7 at 18.00. Your order will be executed when the market is open at 21.30 if the stock drops from $10 to $7 or lower. Similarly, if the stock price doesn’t drop to $7, your order won’t be executed.
Yes, you are eligible to receive dividend payment if and when the company pays them on one condition: minimum net dividend paid is at least $0.01. Net dividend is gross dividend subtracted by 15% withholding tax.
Yes, it is. US Stocks risk is managed by PT PG Berjangka which is licensed by Badan Pengawas Perdagangan Berjangka Komoditi (BAPPEBTI), and your investment is guaranteed by Jakarta Futures Exchange (JFX) and Indonesian Clearing House (KBI).
Pluang charges a fixed transaction fee of 0.30% for regular users and 0.20% for Pluang Plus members, including VAT to cover the exchange fees and operational costs.
US Stocks, ETFs, and Options are facilitated by PT PG Berjangka in its capacity as a Licensed Derivatives Broker supervised by the Financial Services Authority of Indonesia (OJK) for financial derivative products with underlying securities. All transactions are recorded on the Jakarta Futures Exchange (JFX) and the Indonesian Futures Clearing House (KBI). In addition, PT PG Berjangka is also a Licensed Futures Broker supervised by the Commodity Futures Trading Regulatory Agency (Bappebti). Read our product’s Terms and Conditions
All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.

Key Stats

  • Market Cap
    $87.72B
  • Volume
    -
  • Sector
    Health
  • 52W High
    $852.03
  • 52W Low
    $555.51
  • Typical Hold Time
    -
  • Enterprise Value
    $82.43B
  • Div Yield
    0.44%
  • Trading Activity
    -
$843.47
52W Low: $555.51
25 Sep 2025
52W High: $852.03
02 Sep 2026

Track Regeneron Pharmaceuticals Inc (REGN) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Regeneron Pharmaceuticals Inc has traded between a low of $555.51 and a high of $852.03, highlighting its annual price range. Buy and sell Regeneron Pharmaceuticals Inc shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.

Let’s invest in this asset by signing up or download!